254 related articles for article (PubMed ID: 9091654)
1. MedGuide: at last a long-sought opportunity for patient education about prescription drugs.
Marwick C
JAMA; 1997 Mar; 277(12):949-50. PubMed ID: 9091654
[No Abstract] [Full Text] [Related]
2. What drug labels don't tell you.
Consum Rep; 2011 Aug; 76(8):10. PubMed ID: 21770080
[No Abstract] [Full Text] [Related]
3. Prescription drug products; patient labeling requirements: proposed rule.
Fed Regist; 1979 Jul; 44(131 Pt 2):40015-41. PubMed ID: 10242793
[No Abstract] [Full Text] [Related]
4. Encouraging trend on prescription drug information.
Marwick C
JAMA; 1997 Jun; 277(22):1746-7. PubMed ID: 9178774
[No Abstract] [Full Text] [Related]
5. Patient package inserts: the proper prescription?
Rowe HM
Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988
[No Abstract] [Full Text] [Related]
6. Black box warnings in prescription drug labeling: results of a survey of 206 drugs.
Beach JE; Faich GA; Bormel FG; Sasinowski FJ
Food Drug Law J; 1998; 53(3):403-11. PubMed ID: 10346718
[No Abstract] [Full Text] [Related]
7. The National Council on Patient Information and Education.
Sasich LD; Wolfe SM; Pearson C; Swankin DA; Levin AA; Beard J
JAMA; 1997 Nov; 278(18):1491-2. PubMed ID: 9363963
[No Abstract] [Full Text] [Related]
8. Requirements for FDA-approved patient information spelled out in final rule.
Am J Health Syst Pharm; 1999 Jan; 56(2):107-8. PubMed ID: 10030523
[No Abstract] [Full Text] [Related]
9. Rules set for dissemination of off-label-use information.
Miller JL
Am J Health Syst Pharm; 1999 Feb; 56(3):204. PubMed ID: 10030500
[No Abstract] [Full Text] [Related]
10. Prescription drug product labeling; medication guide requirements--FDA. Final rule.
Fed Regist; 1998 Dec; 63(230):66378-400. PubMed ID: 10338877
[TBL] [Abstract][Full Text] [Related]
11. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285
[TBL] [Abstract][Full Text] [Related]
12. Regulation of pharmacoeconomics and outcomes research.
Radensky P
Value Health; 2001; 4(1):12-5. PubMed ID: 11704968
[No Abstract] [Full Text] [Related]
13. Stoning a dead bird: advertising limits on approved new drugs.
Strobos J
Food Drug Law J; 1995; 50(4):533-51. PubMed ID: 10343018
[No Abstract] [Full Text] [Related]
14. To inform or persuade? Direct-to-consumer advertising of prescription drugs.
Berndt ER
N Engl J Med; 2005 Jan; 352(4):325-8. PubMed ID: 15673797
[No Abstract] [Full Text] [Related]
15. Drug information leaflets for consumers need improvement, FDA says.
Traynor K
Am J Health Syst Pharm; 2002 Aug; 59(16):1498, 1501. PubMed ID: 12185823
[No Abstract] [Full Text] [Related]
16. The patient package insert--health care provider's friend or foe?
Hirsh HL
Nurs Homes; 1979; 28(4):24-5. PubMed ID: 10283734
[No Abstract] [Full Text] [Related]
17. FDA delays proposal on patient drug information.
Am J Health Syst Pharm; 1995 Feb; 52(4):355-6. PubMed ID: 7757853
[No Abstract] [Full Text] [Related]
18. FDA's Rx for better medication information.
Farley D
FDA Consum; 1995 Nov; 29(9):5-10. PubMed ID: 10152787
[TBL] [Abstract][Full Text] [Related]
19. Is the information "fair and balanced" in direct-to-consumer prescription drug websites?
Huh J; Cude BJ
J Health Commun; 2004; 9(6):529-40. PubMed ID: 15764451
[TBL] [Abstract][Full Text] [Related]
20. Direct-to-consumer prescription drug advertising.
Terzian TV
Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573
[No Abstract] [Full Text] [Related]
[Next] [New Search]
